From: Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft
Groups (treatment days)#
TWI*
(%)
TRD§
(days)
a) EP (days 6-13)
25
8
b) G3139 (days 6-10)
26
9
c) G3139/EP (days 6-10)
51
18
d) DDP (days 6-8)
31
10
e) DDP/EP (days 6-8)
43
15
f) G3139/DDP (days 6-13)
52
20
g) G3139/DDP/EP (days 6-13)
74
30